Therapeutical interest of statins in the treatment of atherosclerosis;Interés terapéutico de las estatinas en el tratamiento de la aterosclerosis

Ars Pharmaceutica

Volumn 40, Issue 4, 1999, Pages 217-231

  De Sotomayor, Álvarez ^a   Herrera, M D ^a   Perez Guerrero C ^a   Marhuenda, E ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Atherosclerosis; HMG Co A reductase; LDL endothelium; Nitric oxide; Statins

Indexed keywords

EID: 26344438962     PISSN: 00042927     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Alberts A.W. (1998). HMG-Co A reductase inhibitors-the developement. Atherosclerosis Rev., 18: 123-131.
2. Alfón J., Guash J.F.., Berrozpe M., Badimón L. (1999). Nitric oxide synthase II (NOS II) gene expression correlates with atherosclerotic intimai thickening. Preventive effects if HMG-Co A reductase inhibitors. Atherosclerosis., 145: 325-331.
3. Álvarez de Sotomayor M., Pérez-Guerrero C., Herrera M.D., Marhuenda E. (1999). Effects of chronic treatment with simvastatin on endothelial disfunction in spontaneously hypertensive rats. Journal of hypertension., 17: 769-776.
4. Anderson T.J., Gerhard M.D., Meredith I.T., Charbonneau F., Delagrange D., Greager M.A., Sehwyn A.P., Ganz P. (1995a). Systemic nature of endothelial dysfunction in atherosclerosis. Am J Cardiol., 75: 71B-75B.